Try Premium for 30 days

Live games for all NFL, MLB, NBA, & NHL teams
Commercial-Free Music
No Display Ads
Otsuka Podcast-logo

Otsuka Podcast

Business & Economics Podcasts >

More Information


Vol. 101: Otsuka and NASCAR Race Together to Champion Mental Health

See the full story with pictures at: Otsuka America Pharmaceutical, Inc. and the National Association for Stock Car Auto Racing (NASCAR) team Chip Ganassi Racing (CGR) joined together to mark Mental Health Awareness Week at Charlotte, North Carolina on October 7th and 8th, 2017. In the US, NASCAR is second only to American Football as the most popular sport in the country in terms of both television viewers and live...


Vol. 100: Developing Heroes On and Off the Futsal Pitch

Sports are good for the body, mind and spirit. Participating in sports boosts self-esteem, team-work and leadership skills, and provides a channel for young people to relieve stress. Five years ago, the Korean Ministry of Education launched an initiative to encourage sports club activities in schools. In support of this initiative, Donga Otsuka, an Otsuka affiliate and manufacturer of POCARI SWEAT for the Korean market, launched a tournament intended to help young people learn the twin...


Vol. 99: Otsuka Recognized at the Polycystic Kidney Disease Foundation Gratitude Event

See the full story with pictures at On April 22, 2017, the Polycystic Kidney Disease (PKD) Foundation honored Otsuka Pharmaceutical for our long-standing and successful commitment to develop an innovative, first-in-class drug treatment for autosomal dominant polycystic kidney disease (ADPKD) and for its collaboration with the foundation. “Working together with basic science funded by PKD Foundation and the...


Vol. 98: Clinical Access Program for MDR-TB Medicine Launched in South Africa

See the full story with pictures at On World TB Day, March 24th 2017, Otsuka Pharmaceutical in cooperation with South Africa’s Ministry of Health and a non-governmental organization called Right to Care, officially launched DCAP, a clinical access program for delamanid (DeltybaTM), a medicine developed by Otsuka for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The event, organized by...


Vol. 97: Astex employees get walking for blood cancer charity

See the full story with pictures at Every year since 2000, Astex employees and their families have taken part in the Light The Night of East Bay event in Walnut Creek in Northern California to raise much needed funds and awareness to support the Leukemia and Lymphoma Society (LLS). The LLS, founded in 1949, is the largest voluntary organization in the US dedicated to research, finding cures and ensuring access to treatment for blood cancer...


Vol. 96: Nutrition & Santé wins top national award for sustainability efforts

See the full story with pictures at Otsuka Group member Nutrition & Santé, a leading manufacturer of dietetic products including slimming and sports foods, won the 2017 Inaugural Grand Prix Award from the French National Association of Food Industries (ANIA) and EY *1 at an award ceremony held on January 18th. The prize rewards French food industry companies for their growth in France or overseas, for job creation, and for their commitment...


Vol. 95: Opening of the RIKEN CDB-Otsuka Pharmaceutical Collaboration Center

See the full story with pictures at In September of 2016, Otsuka Pharmaceutical and RIKEN opened the RIKEN CDB-Otsuka Pharmaceutical Collaboration Center (COCC) inside the RIKEN Center for Developmental Biology (RIKEN CDB), which is located in the city of Kobe. The COCC will be involved in collaborative developmental biology and regenerative medicine research projects with the goal of investigating disease mechanisms and discovering...


Vol. 94: Otsuka Develops a New Pill Dispenser with NEC Using IoT Technologies

Read the full story with photos at: Otsuka Pharmaceutical and NEC Corporation have partnered to jointly develop a smart medicine container that will help ensure that patients do not forget to take their daily dose of anti-stroke medication. Otsuka has experience with patients who have suffered one or more strokes through its involvement in the research, development and marketing of blood-thinning drugs, and NEC has many years of experience...


Vol. 92: Educational awareness tool for nerve & mental diseases wins at Cannes

Watch the video of this award-winning tool at: A portion of our activities dedicated to reducing bias among the general public about nerve and mental diseases has won the Bronze for the Pharma category of Lions Health at the 63rd Cannes Lions International Festival of Creativity, the most prestigious international award for creativity. The activity which was awarded the Bronze uses the booklet “Connect Pen...


Vol. 91: A New Partner for Global Health Innovative Technology (GHIT) Fund

Read the full story with photos at Otsuka Pharmaceutical participated in the Global Health Innovative Technology (GHIT) Fund as an associate partner on June 7th, 2016. GHIT Fund was established in April 2013 as the world’s first product development fund specialized in Global Health through partnerships with the public (i.e. Japanese government), private, and civil sectors (Bill & Melinda Gates Foundation,...


Vol. 90: Otsuka Hosted First-Ever Documentary About PseudoBulbar Affect

Read the full story with photos at: Otsuka America Pharmaceutical, Inc. hosted a special screening of the first-ever documentary film on living with PseudoBulbar affect (PBA), “Beyond Laughter and Tears, A Journey of Hope”, during the American Psychiatric Association (APA) annual meeting in Atlanta on May 16, 2016. The documentary was created by Avanir Pharmaceuticals, Inc., an Otsuka subsidiary, in order...


Vol. 89: US Otsuka Pharmaceutical Colleague Honored for Leadership

See the full story with photos at Mr. Bob Oliver, president & CEO of Otsuka America Pharmaceutical, Inc., (OAPI), served as the keynote speaker and honoree at the 3rd Annual Top Blacks in Healthcare Awards Gala held in spring this year in Baltimore. The Gala, hosted by, a leading online health destination for African Americans, and the Johns Hopkins Center for Health Disparities Solutions,...


Vol. 88: Minister of Education, Culture, Sports, Science and Technology Honored Otsuka 2 Awards

Read the original article with photos at: The Minister of Education, Culture, Sports, Science and Technology awarded Otsuka Pharmaceutical Co., Ltd. two commendations for Science and Technology in Tokyo, Japan. One of the prizes for Science and Technology, in the Development Category, was for the research and development of delamanid. It is an effective treatment for multi-drug resistant tuberculosis. The...


Vol. 87: Delamanid Available To 100+ Countries Through an Innovative Partnership

Read the full article with photos at Otsuka and the Stop TB Partnership’s Global Drug Facility (GDF) announced a worldwide access plan for delamanid, one of only two medications approved to treat multidrug-resistant tuberculosis (MDR-TB) in the last 40 years. The GDF is the largest supplier of quality assured TB treatments in the public sector, which gives it a unique position to catalyse uptake and...


Vol. 77: The Sixth Annual Sistine Kabuki With a Modern Twist of Technology

Read the full article with photos at The Otsuka Museum of Art hosted the sixth Sistine Kabuki production – Yuriwaka Daijin: Ulysses – for 3 days, beginning on February 20, with two performances each day. As has been the case in past years, tickets sold out almost as soon as they went on sale. The performances were attended by 2800 persons from across Japan. Incorporating Technology in Kabuki The stage for this year's...


Vol. 86: Winner Announced for Otsuka’s 2nd Annual Young Innovator in Tuberculosis Research Award

Read the full story with photos at Dr. Gregory Fox from Sydney, Australia was presented the Young Innovator in Tuberculosis Research Award sponsored by Otsuka during the 46th Union World Conference on Lung Health in Cape Town, South Africa in December 2015. Dr. Fox is an Australian respiratory physician and recipient of the CJ Martin Fellowship from the Australian Government. His research focuses on TB...


Vol. 85: Otsuka’s Mai Ito Qualifies for 2016 Olympics! Big Congratulations for Finishing 7th in Women’s Marathon at the World Championships in Athletics

Read the full story with photos at On the final day of the 15th IAAF World Championships held in Beijing, Mai Ito from the Otsuka Pharmaceutical Track & Field Team ran for Japan in the Women’s Marathon. Although the final day was cloudy compared to the blazing weather throughout the games, Ms. Ito ran confidently in hot conditions and finished first among all Japanese runners, earning her the right to run...


Vol. 83: Attention, Gourmets in Hong Kong! Roll-Out of Three Nutraceutical Delights

Read the full article with photos at: In ‘the city of sizzling woks’ with over 12,000 restaurants to dine at, you cannot avoid the scrumptious cooking aromas at any street corner. Hong Kong is a world-renowned gourmet paradise for its creative East-meets-West culinary delicacies, and for the accessibility there to imported foods from around the world. Some of the culinary pleasures of being in Hong Kong are...


Vol. 82: Otsuka America Proudly Supports NCSS Cherry Blossom Festival Events

Read the full article with photos at: Otsuka is proud to be the lead supporter of the National Conference of State Societies’ (NCSS) 67th Cherry Blossom Festival events, including their flagship Cherry Blossom Princess Program. Otsuka has pledged its recurring support to the NCSS Cherry Blossom Events for three consecutive years, to demonstrate the company’s commitment to empowering young women to aspire to...


See More